EPHA2 and breast cancer: We thus cloned the 3′UTR miR-1297-binding sequence of EPHA2 into the pMir Target vector (Figure 1d) and used this plasmid to assess the binding miR-1297 and its activity on the EPHA2 3’UTR by performing luciferase assays in MCF7 BC cells.